increasing evidence strongly supports the key role of neuroinflammation in the pathophysiology of neurodegenerative diseases, such as alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. neuroinflammation may alter synaptic transmission contributing to the progression of neurodegeneration, as largely documented in animal models and in patients' studies. In the last few years, palmitoylethanolamide (PEA), an endogenous lipid mediator, and its new composite, which is a formulation constituted of PEA and the well-recognized antioxidant flavonoid luteolin (Lut) subjected to an ultra-micronization process (co-ultraPEALut), has been identified as a potential therapeutic agent in different disorders by exerting potential beneficial effects on neurodegeneration and neuroinflammation by modulating synaptic transmission. in this review, we will show the potential therapeutic effects of PEA in animal models and in patients affected by neurodegenerative disorders.
Assogna, M., DI LORENZO, F., Martorana, A., Koch, G. (2022). Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders. BIOMOLECULES, 12(8) [10.3390/biom12081161].
Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
Martina Assogna;Francesco Di Lorenzo;Alessandro Martorana;
2022-01-01
Abstract
increasing evidence strongly supports the key role of neuroinflammation in the pathophysiology of neurodegenerative diseases, such as alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. neuroinflammation may alter synaptic transmission contributing to the progression of neurodegeneration, as largely documented in animal models and in patients' studies. In the last few years, palmitoylethanolamide (PEA), an endogenous lipid mediator, and its new composite, which is a formulation constituted of PEA and the well-recognized antioxidant flavonoid luteolin (Lut) subjected to an ultra-micronization process (co-ultraPEALut), has been identified as a potential therapeutic agent in different disorders by exerting potential beneficial effects on neurodegeneration and neuroinflammation by modulating synaptic transmission. in this review, we will show the potential therapeutic effects of PEA in animal models and in patients affected by neurodegenerative disorders.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
